Literature DB >> 25148759

Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers.

Karon F Cook1, David E Victorson, David Cella, Benjamin D Schalet, Deborah Miller.   

Abstract

PURPOSE: To establish clinically relevant classifications of health outcome scores for four Neuro-QOL measures (lower extremity function, upper extremity function, fatigue, and sleep disturbance).
METHODS: We employed a modified educational standard-setting methodology to identify cut-scores for symptom severity. Clinical vignettes were developed to represent graduated levels of symptom severity. A clinician panel and a panel of persons with multiple sclerosis (PwMS) were recruited, and, in separate, 1-day meetings, the panelists identified adjacent vignettes they judged to represent the threshold between two levels of severity for a given domain (e.g., threshold between a vignette that indicated "no problems" with sleep and the adjacent one that represented "mild problems" with sleep). Working independently, each panel (PwMS and clinicians) reached consensus on its recommended thresholds for each of the four targeted measures. Cut-scores were defined as the mean location for each pair of threshold vignettes.
RESULTS: PwMS and clinician panels derived identical thresholds for severity levels of lower extremity function and sleep disturbance, but slightly different ones for upper extremity function and fatigue. In every case of divergence, PwMS set higher thresholds for more severe classifications of symptoms (by 0.5 SDs) than did clinicians.
CONCLUSIONS: The modified bookmarking method is effective for defining thresholds for symptom severity based on self-reported outcome scores and consensus judgments. Derived cut-scores and severity levels provide an interpretative context for Neuro-QOL scores. Future studies should explore whether these findings can be replicated and evaluate the validity of the classifications compared to external criteria.

Entities:  

Mesh:

Year:  2014        PMID: 25148759     DOI: 10.1007/s11136-014-0790-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  39 in total

1.  Quality of life is not favorable for most patients with multiple sclerosis.

Authors:  Alex J Mitchell; Julían Benito-León; Jesús Rivera-Navarro; José Manuel Morales-González
Journal:  Arch Neurol       Date:  2004-11

Review 2.  Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Authors:  Deborah M Miller; Rebecca Allen
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

3.  Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

Authors:  Diane C Zelman; Ellen Dukes; Nancy Brandenburg; Alan Bostrom; Mugdha Gore
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

4.  How common are the "common" neurologic disorders?

Authors:  D Hirtz; D J Thurman; K Gwinn-Hardy; M Mohamed; A R Chaudhuri; R Zalutsky
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

5.  Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.

Authors:  David Cella; Seung Choi; Sofia Garcia; Karon F Cook; Sarah Rosenbloom; Jin-Shei Lai; Donna Surges Tatum; Richard Gershon
Journal:  Qual Life Res       Date:  2014-06-18       Impact factor: 4.147

6.  Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?

Authors:  Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Pain Symptom Manage       Date:  2007-12-26       Impact factor: 3.612

7.  The creation of protection and hope in patients with malignant brain tumours.

Authors:  P Salander; T Bergenheim; R Henriksson
Journal:  Soc Sci Med       Date:  1996-04       Impact factor: 4.634

8.  Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis.

Authors:  Diane C Zelman; Deborah L Hoffman; Raafat Seifeldin; Ellen M Dukes
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

9.  Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Authors:  D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

10.  Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life.

Authors:  Deborah Miller; Richard A Rudick; Michael Hutchinson
Journal:  Neurology       Date:  2010-04-27       Impact factor: 9.910

View more
  19 in total

1.  Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma.

Authors:  David Cella; Robert J Motzer; Brian I Rini; Joseph C Cappelleri; Krishnan Ramaswamy; Subramanian Hariharan; Bhakti Arondekar; Andrew G Bushmakin
Journal:  Value Health       Date:  2018-05-11       Impact factor: 5.725

2.  Evaluation of options for presenting health-states from PROMIS® item banks for valuation exercises.

Authors:  Janel Hanmer; David Cella; David Feeny; Baruch Fischhoff; Ron D Hays; Rachel Hess; Paul A Pilkonis; Dennis Revicki; Mark Roberts; Joel Tsevat; Lan Yu
Journal:  Qual Life Res       Date:  2018-04-12       Impact factor: 4.147

3.  Idio Scale Judgment: evaluation of a new method for estimating responder thresholds.

Authors:  Karon F Cook; Michael A Kallen; Cheryl D Coon; David Victorson; Deborah M Miller
Journal:  Qual Life Res       Date:  2017-06-17       Impact factor: 4.147

Review 4.  Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.

Authors:  Cindy J Nowinski; Deborah M Miller; David Cella
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

5.  Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting.

Authors:  Nan E Rothrock; Karon F Cook; Mary O'Connor; David Cella; Ashley Wilder Smith; Susan E Yount
Journal:  Qual Life Res       Date:  2019-08-13       Impact factor: 4.147

6.  Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method.

Authors:  David Thissen; Yang Liu; Brooke Magnus; Hally Quinn; Debbie S Gipson; Carlton Dampier; I-Chan Huang; Pamela S Hinds; David T Selewski; Bryce B Reeve; Heather E Gross; Darren A DeWalt
Journal:  Qual Life Res       Date:  2015-06-29       Impact factor: 4.147

7.  Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers.

Authors:  Esi M Morgan; Constance A Mara; Bin Huang; Kimberly Barnett; Adam C Carle; Jennifer E Farrell; Karon F Cook
Journal:  Qual Life Res       Date:  2016-12-02       Impact factor: 4.147

8.  Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis.

Authors:  Deborah M Miller; Francois Bethoux; David Victorson; Cindy J Nowinski; Sarah Buono; Jin-Shei Lai; Katy Wortman; James L Burns; Claudia Moy; David Cella
Journal:  Mult Scler       Date:  2015-08-03       Impact factor: 6.312

9.  Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases.

Authors:  Vivek Nagaraja; Constance Mara; Puja P Khanna; Rajaie Namas; Amber Young; David A Fox; Timothy Laing; William J McCune; Carol Dodge; Debra Rizzo; Maha Almackenzie; Dinesh Khanna
Journal:  Qual Life Res       Date:  2017-10-05       Impact factor: 4.147

10.  Interpreting Life Impact Burn Recovery Evaluation Profile Scores for Use by Clinicians, Burn Survivors, and Researchers.

Authors:  Mary D Slavin; Colleen M Ryan; Jeffrey C Schneider; Amy Acton; Flor Amaya; Cayla Saret; Emily Ohrtman; Audrey Wolfe; Pengsheng Ni; Lewis E Kazis
Journal:  J Burn Care Res       Date:  2021-02-03       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.